Project Pitlane unites Formula 1 teams in fighting COVID-19

Britain-based Formula 1 teams have joined forces under the auspices of Project Pitlane to assist the government in their fight against the coronavirus pandemic that is sweeping the world at an alarming rate.

Essential medical equipment and supplies are in high demand as existing resources are stretched to the limit and in some instances to breaking point. With F1 teams in hiatus, awaiting the uncertain future of a season already in tatters thanks to COVID-19.

F1 announced in a press release:

“As confirmed today by the United Kingdom Government, during the past two weeks a collective of seven UK-based Formula 1 teams,* their respective technology arms and Formula 1 has made significant progress in defining and coordinating its response to the UK Government’s call for assistance with the manufacture of medical devices to help in the treatment of COVID-19 patients.

“The seven teams’ combined efforts, termed ‘Project Pitlane’, are part of a UK industry-wide effort to manufacture and deliver respiratory devices to support the national need.

“Following decisions taken this week by the UK Government, Project Pitlane is focussed on three workstreams. These workstreams vary in scope from reverse engineering existing medical devices, to support in scaling the production of existing ventilator designs as part of the VentilatorChallengeUK consortium, to the rapid design and prototype manufacture of a new device for certification and subsequent production.

“In each instance, Project Pitlane will pool the resources and capabilities of its member teams to greatest effect, focusing on the core skills of the F1 industry: rapid design, prototype manufacture, test and skilled assembly. F1’s unique ability to rapidly respond to engineering and technological challenges allows the group to add value to the wider engineering industry’s response.

“The focus of Project Pitlane will now be on coordinating and answering the clear challenges that have been set. The seven teams remain ready to support in other areas requiring rapid, innovative technology responses to the unique challenges posed by the COVID-19 pandemic.”